Save time and jump to the most important pieces.
TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to
American Oncology Network, LLC ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the "Business Combination"). The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC ("Nasdaq") under the new ticker symbol "AONC" on September 21, 2023. The Business Combination was approved at a special meeting of DTOC's stockholders on September 19
Gainers MSP Recovery, Inc. (NASDAQ:LIFW) shares jumped 104.5% to $0.1916. Digital Transformation Opportunities Corp. (NASDAQ:DTOC) rose 100.7% to $27.50 after dipping 53% on Tuesday. Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 56.4% to $4.8499. Bluejay Diagnostics, last month, announced a $1.59 million registered direct offering of 216,000 shares at $7.365 per share. Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX) shares gained 50% to $0.8705 after the company announced its Board of Directors has approved a plan of liquidation and dissolution. AgriFORCE Growing Systems Ltd. (NASDAQ:AGRI) rose 38% to $0.1478. TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares gained 32.9% to $0.6974
FORT MYERS, Fla. and LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, LLC ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the "Business Combination"). The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC ("Nasdaq") under the new ticker symbol "AONC" on September 21, 2023. The Business Combination
TORONTO, Jan. 11, 2023 /CNW/ - D2L Inc. (TSX:DTOL) ("D2L" or the "Company"), a leading global learning technology company, today announced the appointment of technology executive Heather Zynczak to its Board of Directors. Zynczak spent the past 25 years in marketing, product and revenue leadership positions in technology. She was most recently Chief Marketing Officer of Pluralsight (NASDAQ:PS), where she was responsible for all aspects of marketing and digital revenue. During her tenure at Pluralsight, the company grew B2B revenue over 50% year-over-year, expanding revenue to
American Oncology Network (AON) is a rapidly growing network of community-based oncology practices The proposed transaction values the combined company at a pro forma enterprise value of approximately $500 million American Oncology Network ("AON" or the "Company"), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (NASDAQ:DTOC) ("DTOC"), a special purpose acquisition company focused on the healthcare industry, today announced that they have entered into a definitive business combination agreement pursuant to which AON will become a public company (the "Business Combination"). Upon completion of the Business Combination, the
424B5 - American Oncology Network, Inc. (0001839998) (Filer)
EFFECT - American Oncology Network, Inc. (0001839998) (Filer)
S-8 - American Oncology Network, Inc. (0001839998) (Filer)
4/A - American Oncology Network, Inc. (0001839998) (Issuer)
3/A - American Oncology Network, Inc. (0001839998) (Issuer)
4 - American Oncology Network, Inc. (0001839998) (Issuer)
SC 13D - American Oncology Network, Inc. (0001839998) (Subject)
SC 13D/A - American Oncology Network, Inc. (0001839998) (Subject)
SC 13D - American Oncology Network, Inc. (0001839998) (Subject)